Dermatological diseases such as psoriasis, eczema, and alopecia are of great medical and socioeconomic significance, and are a leading cause of nonfatal disease burden for global health care. These diseases are often chronic and can have major physical and emotional impacts on sufferers, significantly reducing their quality of life. While such conditions may be classified as “skin diseases,” their underlying pathophysiology is complex, involving systemic inflammation and autoimmune processes. Exemplifying this complexity, diseases such as psoriasis are thought to be associated with increased cardiovascular risk, including myocardial infarction and stroke. Consequently, dermatological conditions represent both a challenge when it comes to penetrating their underlying biology and developing new and better therapies, and also an opportunity to gain insights into a wider range of mechanistically related diseases. Our panelists will discuss how biomarkers can contribute to these goals by improving our biological understanding and helping us to develop more effective, targeted treatments for patients in the future.
During the webinar, the speakers will:
- Discuss the complex interplay of inflammatory and immunological processes in dermatological disease
- Describe recent progress in understanding pathophysiology and therapeutic opportunities
- Explore future developments and potential advances in this field
- Answer your questions during the live broadcast!
This webinar will last for approximately 60 minutes.